Halogenated Anesthetics | |
Clinical Impact: | Concomitant use may increase cardiac autonomic irritability and can sensitize the myocardium to the action of dopamine which may lead to ventricular arrhythmias and hypertension. |
Intervention: | Monitor cardiac rhythm. |
Examples: | desflurane, enflurane, isoflurane, and sevoflurane. |
MAO Inhibitors | |
Clinical Impact: | Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine which may result in severe hypertension and cardiac arrhythmia. |
Intervention: | Reduce the recommended starting dosage to no greater than one‑tenth (1/10) of the recommended dose in patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of Dopamine HCl Injection. |
Examples: | isocarboxazid, phenelzine, tranylcypromine, rasagiline, selegiline, linezolid. |
Tricyclic Antidepressants | |
Clinical Impact: | Concomitant use may potentiate the cardiovascular effects of dopamine (e.g., hypertension). |
Intervention: | Monitor blood pressure. |
Examples: | amitriptyline, desipramine, doxepin, imipramine, nortriptyline. |
| |
Clinical Impact: | Concomitant use may result in severe hypertension. |
Intervention: | Monitor blood pressure. |
Examples: | norepinephrine, epinephrine, oxytocin. |
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.